Myofibroblast-Derived Exosome Induce Cardiac Endothelial Cell Dysfunction

Prabhat Ranjan1, Rajesh Kumari1, Sumanta Kumar Goswami1

  • 1Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, United States.

Insights

Activated fibroblast exosomes carrying miR-200a-3p impair endothelial cell function. Inhibiting this microRNA in fibroblasts improved endothelial cell biology and vascular homeostasis, highlighting a novel therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Cell Biology
  • Extracellular Vesicles

Background:

  • Endothelial cells (ECs) are crucial for vascular homeostasis and heart function.
  • The impact of fibroblast-derived exosomes on ECs remains unclear, despite their known effects on cardiomyocytes.
  • This study investigates the role of activated cardiac fibroblast-derived exosomes (FB-Exo) in EC dysfunction.

Purpose of the Study:

  • To determine if activated cardiac FB-Exo mediate EC dysfunction.
  • To explore whether modulating FB-exosomal contents can improve endothelial function.
  • To identify specific exosomal components responsible for EC dysfunction.

Main Methods:

  • Exosomes were isolated from cardiac fibroblasts (FB) and characterized.
  • ECs were treated with exosomes from TGF-β1-activated FBs (TGF-β1-FB-Exo) or control FBs.
  • Gene expression, protein phosphorylation, cell proliferation, apoptosis, tube formation, and migration assays were performed.

Main Results:

  • TGF-β1 activated FBs, evidenced by increased collagen and fibronectin expression.
  • TGF-β1-FB-Exo treatment impaired EC function, reducing tube formation, migration, proliferation, and increasing apoptosis.
  • Exosomes from activated FBs showed increased levels of fibrosis-associated microRNAs, notably miR-200a-3p.
  • Inhibition of miR-200a-3p in activated FBs ameliorated EC dysfunction.

Conclusions:

  • Activated fibroblast-derived exosomes play a significant role in endothelial cell dysfunction.
  • miR-200a-3p within these exosomes is a key mediator of endothelial cell biology and function.
  • Targeting exosomal miR-200a-3p presents a potential therapeutic strategy for vascular dysfunction.